Results 141 to 150 of about 99,648 (351)

Fluid intake and recurrence and progression risk of patients with non‐muscle‐invasive bladder cancer

open access: yesBJU International, EarlyView.
Objectives To evaluate the association of pre‐ and post‐diagnosis fluid intake with non‐muscle‐invasive bladder cancer (NMIBC) recurrence and progression risk. Patients and Methods Data were used from the multicentre prospective cohort study UroLife.
Ivy Beeren   +6 more
wiley   +1 more source

Pelvic organ‐sparing robot‐assisted radical cystectomy in women with bladder cancer

open access: yesBJU International, EarlyView.
Objectives To investigate the oncological and complication outcomes in women who have undergone pelvic organ‐sparing robot‐assisted radical cystectomy (RARC). Patients and Methods We conducted a retrospective, multicentre cohort study of women with bladder cancer undergoing RARC with intracorporeal urinary diversion.
Juhana Rautiola   +11 more
wiley   +1 more source

Bladder EpiCheck clinical utility to predict BCG response in non‐muscle‐invasive bladder cancer

open access: yesBJU International, EarlyView.
Objective To evaluate the performance of Bladder Epicheck® (BE; Nucleix Ltd., Rehovot, Israel) in predicting tumour recurrence and bacillus Calmette–Guérin (BCG) failure during the first year after induction treatment. Patients and methods Prospective study including 65 patients with non‐muscle‐invasive bladder cancer treated with BCG between 2018 and ...
Fiorella L. Roldán   +11 more
wiley   +1 more source

Case reported for iatrogenic cystectomy during cesarean delivery

open access: yesUrology Case Reports, 2020
Although bladder injury is a rare complication during cesarean delivery (CD), its incidence is increasing due to the growing trend in elective CD. Herein, we report a case of a 28-year-old woman, who presented during labor.
Muhammad Alahmadi, Abdullah Ahmed Ghazi
doaj  

The impact of treatment for muscle‐invasive bladder cancer on health‐related quality of life

open access: yesBJU International, EarlyView.
Objectives To evaluate the impact of treatment for localised muscle‐invasive bladder cancer (MIBC) during the first 2 years after diagnosis. Patients and Methods A prospective cohort study was conducted including patients diagnosed with non‐metastatic (cM0) MIBC between November 2017 and November 2019 in the Netherlands. Health‐related quality of life (
Siberyn T. Nuijens   +9 more
wiley   +1 more source

Primary Retroperitoneal Mucinous Cystadenoma

open access: yes
ANZ Journal of Surgery, EarlyView.
Yusi Liu, Wei Ming Ong, Alex Wong
wiley   +1 more source

Contemporary outcomes in non‐muscle‐invasive bladder cancer: a large European multicentre study

open access: yesBJU International, EarlyView.
Objective To report real‐world rates of non‐muscle‐invasive bladder cancer (NMIBC) recurrence and progression within a European multicentre cohort with detailed information on intravesical instillation courses, as contemporary data on oncological outcomes in NMIBC are limited.
Mattia Longoni   +28 more
wiley   +1 more source

Insights Into Rural Chemotherapy Usage for Muscle‐Invasive Bladder Cancer: An Australian Multi‐Site Institution Perspective

open access: yes
ANZ Journal of Surgery, EarlyView.
Tran Ngoc An Huynh   +9 more
wiley   +1 more source

What spatial omics is teaching us about field cancerisation in prostate and bladder cancer

open access: yesBJU International, EarlyView.
Background and Objectives Field cancerisation is the process that results in a group of cells acquiring some of the phenotypic changes of cancer prior to transformation into cancer. Clinically, an important challenge remains the ability to distinguish clonal lineages and microenvironments within cancerised fields that will remain indolent from those ...
Matthew H. V. Byrne   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy